33
/es/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512564
319423
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Obtener premium
Create a timeline
Public timelines
FAQ
About & FeedbackAcuerdoPrivacidadFAQ
Support 24/7  
CabinetGet premium
Donate

1 ene 2014 año - Pembrolizumab

Descripción:

Pembrolizumab is approved for advanced melanoma treatment by the FDA. This monoclonal antibody blocks a protein called PD1's activity on immune cells, which increases the strength of the immune response to cancer.

Añadido al timeline:

Cancer

ByTrinity Ozias
14 nov 2019
0
0
302

fecha:

1 ene 2014 año
Ahora mismo
~ 11 years ago
About & FeedbackAcuerdoPrivacidadFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL